Search Results - "Hirotsugu Yamada"

Refine Results
  1. 1

    A Deep Learning Approach for Assessment of Regional Wall Motion Abnormality From Echocardiographic Images by Kusunose, Kenya, Abe, Takashi, Haga, Akihiro, Fukuda, Daiju, Yamada, Hirotsugu, Harada, Masafumi, Sata, Masataka

    Published in JACC. Cardiovascular imaging (01-02-2020)
    “…This study investigated whether a deep convolutional neural network (DCNN) could provide improved detection of regional wall motion abnormalities (RWMAs) and…”
    Get full text
    Journal Article
  2. 2

    Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice by Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, Masataka

    Published in Journal of Atherosclerosis and Thrombosis (01-11-2020)
    “…Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT2is) reduce cardiovascular events, although their mechanism…”
    Get full text
    Journal Article
  3. 3

    Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice by Ganbaatar, Byambasuren, Fukuda, Daiju, Shinohara, Masakazu, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Hirata, Ken-ichi, Sata, Masataka

    Published in European journal of pharmacology (15-05-2020)
    “…Recent studies reported cardioprotective effects of sodium glucose co-transporter 2 (SGLT2) inhibitors; however, the underlying mechanisms are still obscure…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice by Ganbaatar, Byambasuren, Fukuda, Daiju, Shinohara, Masakazu, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Hirata, Ken-ichi, Sata, Masataka

    Published in Journal of Atherosclerosis and Thrombosis (01-06-2021)
    “…Aim: The bioactive lipid, sphingosine-1-phosphate (S1P), has various roles in the physiology and pathophysiology of many diseases. There are five S1P…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation by Matsuura, Tomomi, Soeki, Takeshi, Fukuda, Daiju, Uematsu, Etsuko, Tobiume, Takeshi, Hara, Tomoya, Kusunose, Kenya, Ise, Takayuki, Yamaguchi, Koji, Yagi, Shusuke, Yamada, Hirotsugu, Wakatsuki, Tetsuzo, Sata, Masataka

    Published in Circulation Journal (21-07-2021)
    “…Background:Activated factor X (FXa), which contributes to chronic inflammation via protease-activated receptor 2 (PAR2), might play an important role in atrial…”
    Get full text
    Journal Article
  9. 9

    Report of the American College of Cardiology (ACC) Scientific Sessions 2013, San Francisco: Highlighting Late-Breaking Trials by Yamada, Hirotsugu

    Published in Circulation Journal (2013)
    “…The American College of Cardiology’s (ACC) 62nd Annual Scientific Session was held at the Moscone Center, San Francisco, from March 9–11, 2013. The meeting…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    How to standardize the measurement of left ventricular ejection fraction by Kusunose, Kenya, Zheng, Robert, Yamada, Hirotsugu, Sata, Masataka

    Published in Journal of medical ultrasonics (2001) (01-01-2022)
    “…Despite recent advances in imaging for myocardial deformation, left ventricular ejection fraction (LVEF) is still the most important index for systolic…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice by Pham, Phuong Tran, Fukuda, Daiju, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Shimabukuro, Michio, Sata, Masataka

    Published in Scientific reports (01-08-2019)
    “…Activated factor X (FXa) plays a central role in the coagulation cascade, while it also mediates vascular function through activation of protease-activated…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Prognostic Value of Frailty and Diastolic Dysfunction in Elderly Patients by Kusunose, Kenya, Okushi, Yuichiro, Yamada, Hirotsugu, Nishio, Susumu, Torii, Yuta, Hirata, Yukina, Saijo, Yoshihito, Ise, Takayuki, Yamaguchi, Koji, Yagi, Shusuke, Soeki, Takeshi, Wakatsuki, Tetsuzo, Sata, Masataka

    Published in Circulation Journal (25-07-2018)
    “…Background:High prevalence of frailty and of diastolic dysfunction (DD) in heart failure and high mortality in frail adults have been noted. We characterized…”
    Get full text
    Journal Article
  20. 20

    Does Echocardiographic Epicardial Adipose Tissue Thickness become a Useful Biomarker? by Yamada, Hirotsugu, Sata, Masataka

    Published in Journal of Atherosclerosis and Thrombosis (01-01-2015)
    “…Epicardial adipose tissue (EAT) is ectopic visceral fat surrounding the heart that is located close to the coronary arteries. Excessive EAT has been reported…”
    Get full text
    Journal Article